Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6379327 | 0.90 | TK1 (0.67) | TK1DHFR | |
| SCHEMBL4542151 | 0.89 | TK1 (0.63) | TK1DHFR | |
| SCHEMBL5692576 | 0.89 | TK1 (0.57) | TK1DHFR | |
| SCHEMBL19308099 | 0.88 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL658884 | 0.88 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL24420522 | 0.88 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL7537554 | 0.88 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL316663 | 0.88 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL27054363 | 0.88 | TK1 (0.65) | TK1DHFR | |
| SCHEMBL3272720 | 0.87 | TK1 (0.63) | TK1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240425543-A1 | Synthesis and Biological Activity of Phosphoramidimidate and Phosphoramidate DNA | UNIV COLORADO REGENTS (US) | 2024-12-26 | — | — | US | disclosed |
| US-12030911-B2 | Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030911-B2 | Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA | RNASEH1, RNASE1, DNASE1 | TK1 10/4885DHFR 374/4885 |
| US-20240425543-A1 | Synthesis and Biological Activity of Phosphoramidimidate and Phosphoramidate DNA | RNASEH1, RNASE1, DNASE1 | TK1 10/4885DHFR 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.